Diabetes mellitus and the risk of gastric cancer: a meta-analysis of cohort studies

Zhi‐Feng Miao(Kaohsiung Medical University), Yingying Xu(Wannan Medical College), Huimian Xu(First Hospital of China Medical University), Hao Xu(China Medical University), Tingting Zhao(Lanzhou University Second Hospital), Zhen-ning Wang(First Hospital of China Medical University), Yongxi Song(First Hospital of China Medical University), Ying-Ying Xu(First Hospital of China Medical University)
Oncotarget
March 22, 2017
10.18632/oncotarget.16487
Cited by 81

Related Papers

The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
|The Lancet Oncology|2021|436
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023
|癌症：英文版|2023|412
Biomarkers of aging
|Science China Life Sciences|2023|362
Microenvironment-Responsive Metal-Phenolic Nanozyme Release Platform with Antibacterial, ROS Scavenging, and Osteogenesis for Periodontitis
|ACS Nano|2023|345